Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Sarcoma × Immunotherapy × Clear all

Phase

Status

Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 5 Rectal Neoplasms 3 Lung Neoplasms 2 Unresectable Hepatocellular Carcinoma 1 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumor Cancer 1 Sarcoma 1 Radiation Injuries 1 Pathologic Complete Response 1 Pancreatic Cancer Liver Metastases 1 Neoplasms 1 Neoadjuvant Immunotherapy 1 Locally Advanced Pancreatic Cancer 1 Hyperthermia 1 HER2-Negative Locally Advanced Breast Cancer 1 Gastrointestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma 1 Breast Neoplasms 1 Advanced Rectal Cancer 1

Interventions

Doxorubicin 3 anlotinib 2 Injections 2 toripalimab 1 perflutren 1 pemigatinib 1 pazopanib 1 montelukast 1 liposomal doxorubicin 1 eribulin 1 chlorhexidine gluconate 1 camrelizumab 1 bexmarilimab 1 apatinib 1 X-Rays 1 Trabectedin 1 Tablets 1 Radiotherapy 1 Positron Emission Tomography Computed Tomography 1 Ocoxin 1 Nivolumab 1 Negative-Pressure Wound Therapy 1 KP 1339 1 Ipilimumab 1 Immunotherapy 1 Epirubicin 1 Blood Specimen Collection 1 Biopsy 1 Bandages 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07396116 2026-02-12

FUSION-02

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase NA Not yet recruiting

Radiation Injuries, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡